PharMerica CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-11-10: Form 8-K; Period of report 2010-11-04; Description 2.01 Completion of Acquisition or Disposition of Assets; Details 2.01.
- 2010-11-04: Form 8-K; Period of report 2010-11-04; Description 2.02 Results of Operations and Financial Condition.
- 2010-10-08: Form 8-K/A; Period of report 2010-09-30; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2010-10-05: Form 8-K; Period of report 2010-09-30; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-11-10 | 8-K | 2010-11-04 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On November 4, 2010, PharMerica Corporation (the “Company”), through one of its wholly-owned subsidiaries, Chem Rx Pharmacy Services, LLC, a Delaware limited liability company, acquired substantially all of the assets of Chem Rx Corporation and certain of its wholly-owned subsidiaries (collectively, the “Seller”) for $70,600,000 in cash plus the assumption of specified liabilities related to the assets. | d8k.htm |
| 2010-11-04 | 8-K | 2010-11-04 | 2.02 Results of Operations and Financial Condition | a6498543.htm | |
| 2010-10-08 | 8-K/A | 2010-09-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 30, 2010, the Corporation and Weishar entered into the New Agreement. | d8ka.htm |
| 2010-10-05 | 8-K | 2010-09-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 30, 2010, PharMerica Corporation (the “Corporation”) entered into a Letter Agreement with Gregory Weishar (“Weishar”), the Chief Executive Officer of the Corporation (the “New Agreement”). | d8k.htm |
| 2010-09-28 | 8-K | 2010-09-26 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d8k.htm |
| 2010-08-25 | 8-K | 2010-08-24 | 8.01 Other Events | 8.01 On August 24, 2010, PharMerica Corporation (the “Company”) issued a press release announcing that its Board of Directors has authorized a share repurchase of up to $25 million of the Company’s common stock. | a6407293.htm |
| 2010-08-06 | 8-K | 2010-08-05 | 2.02 Results of Operations and Financial Condition | a6388201.htm | |
| 2010-05-28 | 8-K | 2010-05-26 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The 2010 Annual Meeting of Stockholders of the Company was held on May 26, 2010. | d8k.htm |
| 2010-05-07 | 8-K | 2010-05-06 | 2.02 Results of Operations and Financial Condition | a6281898.htm | |
| 2010-03-22 | 8-K/A | 2010-03-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 16, 2010, PharMerica Corporation (the “Corporation”) and the Corporation’s Chief Executive Officer, Gregory S. Weishar, entered into an Amendment to Employment Agreement (“Amendment No. 2”) to the Letter Agreement dated January 14, 2007, by and between AmerisourceBergen Corporation, Kindred Healthcare, Inc., the Corporation and Mr. Weishar, as amended by Amendment No. 1 thereto dated November 13, 2007, by and between the Corporation and Mr. Weishar (the “Employment Agreement”), to comply with Internal Revenue Code Section 162(m). | d8ka.htm |
| 2010-03-22 | 8-K | 2010-03-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 16, 2010, PharMerica Corporation (the “Corporation”) and the Corporation’s Chief Executive Officer, Gregory S. Weishar, entered into an Amendment to Employment Agreement (“Amendment No. 2”) to the Letter Agreement dated January 14, 2007, by and between AmerisourceBergen Corporation, Kindred Healthcare, Inc., the Corporation and Mr. Weishar, as amended by Amendment No. 1 thereto dated November 13, 2007, by and between the Corporation and Mr. Weishar (the “Employment Agreement”), to comply with Internal Revenue Code Section 162(m). | d8k.htm |
| 2010-03-05 | 8-K | 2010-03-02 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On March 2, 2010, the Audit Committee of the Board of Directors of PharMerica Corporation (the “Company”) dismissed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm. | d8k.htm |
| 2010-02-04 | 8-K/A | 2009-12-31 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 This Current Report on Form 8-K/A amends the Current Report on Form 8-K filed with the Securities and Exchange Commission on January 4, 2010 by PharMerica Corporation, a Delaware corporation (the “Company”), to provide the required financial statements and exhibits in connection with the Company’s acquisition through a wholly-owned subsidiary, of all of the membership interests in Integrity Pharmacy Services, LLC and Integrity Medical Supplies, LLC (collectively “Integrity”), effective as of 10:00 a.m. on December 31, 2009. | d8ka.htm |
| 2010-02-04 | 8-K | 2010-02-04 | 2.02 Results of Operations and Financial Condition | a6168431.htm | |
| 2010-01-04 | 8-K | 2009-12-31 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 Effective December 31, 2009, PharMerica Corporation (the “Company”), through a wholly-owned subsidiary, acquired all of the membership interests in Integrity Pharmacy Services, LLC (“IPS”), and Integrity Medical Supplies, LLC (“IMS” and together with IPS, “Integrity”), from RBW Enterprise LP, a Delaware limited partnership, Selway Investments LP, a Delaware limited partnership, Brian D. Echard, Brooke C. Madonna, as Trustee for Biscuits I Trust, and Brooke C. Madonna, as Trustee for The Charry Trust (collectively, the “Sellers”), for $38.0 million in cash plus $3.3 million to pay off outstanding promissory notes to the Sellers. | d8k.htm |